Spirosure

United States
Strum, Wisconsin, United States, 94566-3107

Company profile

Spirosure company profile

Spirosure develops breath-analysis devices to apply novel breath-based analysis in disease diagnosis and management. Their breath-analysis devices focus on providing non-invasive products for the management of chronic diseases including asthma, COPD, and chronic pulmonary hypertension using a nexus of consumer technologies for preventative healthcare through sensors and algorithms. They enable medical researchers to detect biomarkers in a patient's breath to diagnose and monitor respiratory conditions.

Business identity

Contact email
[email protected]
Phone number
+1 925 388 6370
Operating status
Closed
Company type
For Profit
Employee range
1-10 employees
Founded
2011-01-01, Year

Headquarters

Postal code
94566-3107
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
3
Total equity funding
$41M
Last funding
Series C / $15M / 2018-01-08
Last equity funding
Series C / $15M
Investors
7
Lead investors
2
Founders
2
Articles
8
Closed on
2020-10-06
Exited on
2020-06-03

Founders and investors

Founders

Ryan LeardSolomon Ssenyange

Lead investors

Fosun PharmaNGK SPARK PLUG CO

Investors

Fosun PharmaIconicalNGK SPARK PLUG COOhio Innovation FundSouth Valley Angels